We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Living Donor Liver Transplantation Relatively Safe

By HospiMedica International staff writers
Posted on 29 Jul 2014
A new study shows that right liver lobe donor hepatectomy can be performed with minimal complication rates, increasing the potential donor pool dramatically.

Researchers at Afyon Kocatepe University (AKU; Afyon, Turkey), Ege University (Izmir, Turkey), and International Kent Hospital (Izmir, Turkey) conducted a study to determine the rate of complications associated with surgery in 272 living donors (57.4% male) who underwent right lobe donor hepatectomy between September 2004 and December 2009, after passing an elimination system. More...
Demographic data, intraoperative findings, and complication rates were collected retrospectively. Donor complications were categorized according to the Clavien classification.

The results showed that there was no donor mortality. Grade 1 and 2 complications were observed in 105 (38%) of the donors, with the most common complications being fever of unknown origin and prolonged hyperbilirubinemia. Grade 3 and grade 4 complications were observed in 6 donors (2%) and 3 donors (1%), respectively. Three donors underwent re-operation due to bleeding, with a re-laparatomy rate of 1.10%. One donor—categorized as grade 4B—suffered a small bowel perforation and intra-abdominal sepsis secondary to mechanical bowel obstruction. The study was published in the June 2014 issue of Transplantation Proceedings.

“Living donor liver transplantation has been a new light of hope for patients with end-stage liver failure on the cadaveric waiting list,” concluded lead author Mustafa Ozsoy, MD, and colleagues. “Right liver lobe donor hepatectomy can be performed successfully with minimal complication rates with multidisciplinary and rigorous donor care in the preoperative and postoperative period.”

Traditionally, organs for liver transplant are obtained from deceased donors; unfortunately, there are not enough deceased donor organs available for today's growing list of people who are waiting for one. In a live donor liver transplant, one lobe is removed and transplanted immediately after the recipient's liver has been entirely removed. Live donor liver transplantation is possible because the liver, unlike any other organ in the body, has the ability to regenerate, usually within a period of 4 to 8 weeks after surgery.

Related Links:

Afyon Kocatepe University
Ege University
International Kent Hospital



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Ureteral Dilatation Balloon
Dornier Equinox
Ultrasound Needle Guidance System
SonoSite L25
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.